- Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2 Study Evaluating INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma
This study is looking at a new medicine called INCB099280 for people with a type of skin cancer called advanced cutaneous squamous cell carcinoma. It's for patients whose cancer hasn't been treated with immunotherapy before and can't be cured by surgery or radiotherapy.
For: Treatment of immunotherapy-naive patients with previously untreated or recurrent locally advanced or metastatic cSCC not amenable to curative surgery and/or radiotherapySpain · Netherlands · Finland - Ongoing, recruitingTherapeutic exploratory (Phase II)
A PHASE 2 STUDY EVALUATING INCB099280 IN PARTICIPANTS WITH SELECT SOLID TUMORS WHO ARE IMMUNE CHECKPOINT INHIBITOR–NAÏVE
This study is testing a new medicine called INCB099280 for people with certain advanced solid cancers that haven't been treated with immunotherapy before. Researchers want to see if the medicine shrinks tumors and how safe it is.
For: Recurrent or advanced/metastatic solid tumors who are immunotherapy naive and may or may not have been treated with prior therapy for their disease.Romania · Hungary · Greece - Active not recruitingPHASE2
A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma
This study is looking at a new medicine called INCB099280 for people with advanced skin cancer (cutaneous squamous cell carcinoma). We want to find out if it's safe, how well people can tolerate it, and if it helps treat this type of cancer.
For: Cutaneous Squamous Cell CarcinomaAustralia · Brazil · Canada